To assemble our diagnostic arsenal for HCC, we strategically selected for three protein markers – EpCAM, GPC‐3, and ASGPR – driven by clinical imperatives for enhanced diagnostic potential. This evidence concerns the gene GPC3 and hepatocellular carcinoma.